Event-Driven Stocks

Aditxt, Inc.

ADTXNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 good● 5 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$3,195$133,985$645,176$933,715$105,034—
Operating income−$19.6M−$27.9M−$26.1M−$25.5M−$41.9M−$8.9M
Net income−$43.1M−$40.4M−$32.7M−$27.6M−$46.4M−$9.1M
Total assets$16.5M$32.1M$44.6M$10.7M$16.7M$13.1M
Total liabilities$12.6M$23.9M$28.5M$5.5M$6.5M$2.1M
Equity$5.6M$1.7M$16.1M$5.2M$10.2M$11.0M
EPS (diluted)$-1153.83$-22147415.22$-27038.26$-595.60$-121.18—
Shares out.1.2M1.7M4.8M44.7M14.1M13.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−612542.2%
Net margin
−1349028.2%
Return on equity
−768.3%
Return on assets
−261.0%
Return on capital (ROCE)
−455.5%
Liabilities / assets
76.1%
Debt / equity
2.24×
Book value / share
$4.84
Revenue growth (YoY)
−97.6%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-52.24distress
Accruals / assets
−105.4%clean
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
25
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 5 warning● 1 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202691,4371.0-62.6%
Apr 30, 2026244,5751.0+65.4%
Apr 15, 2026147,9091.0-0.6%
Mar 31, 2026148,7731.0+236.3%
Mar 13, 202644,2311.0-38.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)